Results 231 to 240 of about 82,618 (247)

Efficacy of atorvastatin on renal function in patients with contrast-induced nephropathy after percutaneous coronary intervention. [PDF]

J Cardiothorac Surg
Li H, Wang H, Ren S, Zhou R.
europepmc   +1 more source

The predictive value of triglyceride glucose-body mass index for contrast-induced nephropathy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. [PDF]

Sci Rep
Liu L, Yuan Z, Ning X, Wang J, Li Y, Song X, Zhang F.   +6 more
europepmc   +1 more source

Efficacy of the Renal-guard system in the prevention of contrast-induced nephropathy following cardiac interventions among patients with chronic kidney disease. [PDF]

Front Cardiovasc Med
Yasmin F, Mashkoor Y, Najeeb H, Shaikh AA, Nusrat B, Moeed A, Asghar MS, Alraies C.   +7 more
europepmc   +1 more source

Evaluating the Role of Allopurinol in Mitigating Contrast-Induced Nephropathy in Percutaneous Coronary Intervention Patients: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Badreldin H, Mallya Prabhakar P.
europepmc   +1 more source

Comparative Efficacy of High-Dose Rosuvastatin and Atorvastatin in Preventing Cystatin C-Oriented Contrast-Induced Nephropathy in Patients With Acute Myocardial Infarction: RACCOON-AMI Registry. [PDF]

J Korean Med Sci
Kim JH, Kim H, Choi SH, Chun WJ, Doh JH, Lee JY, Lee SJ, Kim BJ.   +7 more
europepmc   +1 more source

Vitamin E for the Prevention of Contrast-Induced Nephropathy: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Awaji AA, Bakhamees BH, Alalshaikh NK, Albelwi NM, Al-Zahrani MM, Alshammari KF, Almutairi SD, Siraj IM, Aljaber TN, Alnajdi RS, Al-Majnooni SS, Alserhani AS.   +11 more
europepmc   +1 more source

Association between the triglyceride-glucose index and contrast-induced nephropathy in chronic total occlusion patients undergoing percutaneous coronary intervention. [PDF]

BMC Cardiovasc Disord
Söner S, Aktan A, Kılıç R, Güzel H, Taştan E, Okşul M, Cömert AD, Coşkun MS, Söner HT, Güzel T.   +9 more
europepmc   +1 more source

How to Construct an Optimal Risk Model for Contrast-induced Nephropathy. [PDF]

Intern Med
Kataoka N, Imamura T.
europepmc   +1 more source

Protective effect of pentoxifylline on contrast induced nephropathy

Saudi Journal of Kidney Diseases and Transplantation, 2008
Roozbeh Jamshid, Jahromi Alireza, Sharifian Maryam, Pakfetrat Maryam, Afshariani Raha   +4 more
doaj